Preprint / Version 1

West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19

Authors

  • Temidayo Popoola Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, L3 3AF UK
  • Peter Segun Department of Pharmacognosy, Faculty of Pharmacy, Olabisi Onabanjo University, Ogun State, Sagamu Campus, Nigeria
  • Edmund Ekuadzi Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • Rita Dickson Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • Olanrewaju Awotona Department of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Legacy University, No. 55, Kairaba Avenue, Fajara, Banjul, The Gambia
  • Lutfun Nahar Laboratory of Growth Regulators, Institute of Experimental Botany, ASCR & Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic
  • Satyajit Sarker Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, L3 3AF UK
  • Amos Fatokun Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool, L3 3AF UK

Keywords:

Antiviral, Medicinal Plants, Traditional Medicine, SARS-CoV-2, COVID-19, West Africa

Abstract

Objectives The recent emergence of the COVID-19 pandemic (caused by SARS-CoV-2) and the experience of its unprecedented alarming toll on humanity have shone a fresh spotlight on the weakness of global preparedness for pandemics, significant health inequalities, and the fragility of healthcare systems in certain regions of the world. It is imperative to identify effective drug treatments for COVID-19. Therefore, the objective of this review is to present a unique and contextualised collection of antiviral natural plants or remedies from the West African sub-region as existing or potential treatments for viral infections, including COVID-19, with emphasis on their mechanisms of action. Evidence acquisition Evidence was synthesised from the literature using appropriate keywords as search terms within scientific databases such as Scopus, PubMed, Web of Science and Google Scholar. Results While some vaccines and small-molecule drugs are now available to combat COVID-19, access to these therapeutic entities in many countries is still quite limited. In addition, significant aspects of the symptomatology, pathophysiology and long-term prognosis of the infection yet remain unknown. The existing therapeutic armamentarium, therefore, requires significant expansion. There is evidence that natural products with antiviral effects have been used in successfully managing COVID-19 symptoms and could be developed as anti-COVID-19 agents which act through host- and virus-based molecular targets. Conclusion Natural products could be successfully exploited for treating viral infections/diseases, including COVID-19. Strengthening natural products research capacity in developing countries is, therefore, a key strategy for reducing health inequalities, improving global health, and enhancing preparedness for future pandemics. Graphical abstract Keywords: Antiviral, Medicinal Plants, Traditional Medicine, SARS-CoV-2, COVID-19, West Africa

Downloads